Stocks

The table gives an overview of all stocks, alphabetically sorted.
 AB INBEV ABI Apr 20, 2021 55.73 -2.33   
 ABO-Group ABO Apr 20, 2021 6.30 -2.33   
 Acacia Pharma Group Plc ACPH Apr 20, 2021 2.31 -1.70   
 Accentis S.A. ACCB Apr 20, 2021 0.05 -1.85   
 Ackermans & van Haaren NV ACKB Apr 20, 2021 131.60 -1.64   
 Aedifica SA AED Apr 20, 2021 104.00 +1.36   
 Ageas AGS Apr 20, 2021 50.70 -1.44   
 AGFA-Gevaert NV AGFB Apr 20, 2021 4.12 +0.98   
 AHOLD DEL AD Apr 20, 2021 22.75 -1.32   
 Antares Certificates ANT Apr 20, 2021 45.41 0.00   
 APERAM APAM Apr 20, 2021 42.90 -1.29   
 Argen X SE ARGX Apr 20, 2021 227.90 -1.00   
 Ascencio Sca ASC Apr 20, 2021 46.90 -0.11   
 ASIT biotech SA ASIT Apr 20, 2021 0.54 +38.97   
 Assicurazioni Generali SpA GEN Apr 20, 2021 17.33 0.00   
 Atenor ATEB Apr 20, 2021 62.80 0.00   
 AVANTIUM AVTX Apr 20, 2021 5.26 -4.54   
 Balta Group N.V. BALTA Apr 20, 2021 2.54 +0.40   
 Banco Bilbao Vizcaya Argentaria SA BBV Apr 20, 2021 4.53 0.00   
 Banco Santander SA SANTA Apr 20, 2021 2.88 -2.18   
 Banimmo BANI Apr 20, 2021 3.12 -0.64   
 Banque Nationale de Belgique BNB Apr 20, 2021 1 865.00 +0.27   
 Barco NV BAR Apr 20, 2021 18.50 -4.05   
 Basilix BAS Apr 20, 2021 9.93 +0.06   
 Beaulieu Av Certificates BEAB Apr 20, 2021 10.71 0.00   
 Befimmo SA BEFB Apr 20, 2021 35.70 +0.28   
 Bel20 BEL20 Apr 20, 2021 3 946.37 -1.26   
 Belreca - Belgian Resources and Capital Company BELR Apr 20, 2021 128.00 0.00   
 Beluga BELU Apr 20, 2021 3.30 0.00   
 Biocartis Group NV BCART Apr 20, 2021 4.42 +1.49   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK